Pricing Log in Create free account

RVL Pharmaceuticals PLC (RVLP) vs Tvardi Therapeutics, Inc. (TVRD)

RVL Pharmaceuticals PLC and Tvardi Therapeutics, Inc. are both Biotechnology companies. RVL Pharmaceuticals PLC and Tvardi Therapeutics, Inc. are of similar size ($14.3M and $14.1M). RVL Pharmaceuticals PLC grew revenue faster over the last twelve months: 5.64% against −34.4%. Tvardi Therapeutics, Inc. has the higher net margin (0.00% vs −184.9%) and the higher return on invested capital (0.00% vs −80.5%). Across the 16 metrics below, Tvardi Therapeutics, Inc. leads on 10 and RVL Pharmaceuticals PLC on 6.

Valuation

Metric RVLP TVRD Biotechnology median
P/E n/m n/m 8.50
P/S n/m 0.85 9.71
P/B n/m 1.13 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.05 4.79 9.21
Earnings yield 0.00% (276.24%) (33.15%)
Free cash flow yield 0.00% (297.28%) (25.50%)

Profitability

Metric RVLP TVRD Biotechnology median
Gross margin 74.73% 100.00% 65.16%
Operating margin (191.72%) 0.00% 0.00%
Net margin (184.91%) 0.00% 0.00%
Free cash flow margin (128.42%) 0.00% 0.00%
Return on equity (182.44%) (126.19%) (56.36%)
Return on assets (64.94%) (85.08%) (48.04%)
Return on invested capital (80.54%) 0.00% 0.00%

Growth

Metric RVLP TVRD Biotechnology median
Revenue growth (TTM) 5.64% (34.36%) 6.02%
EPS growth (last fiscal year) 39.58% 79.51% 30.26%
Revenue growth, 5-year CAGR (27.35%) (18.53%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RVLP TVRD Biotechnology median
Debt to equity 3.54 0.00 0.00
Current ratio 0.38 1.87 4.72
Net debt to EBITDA (0.29) 1.15 0.96

Dividend

Metric RVLP TVRD Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric RVLP TVRD Biotechnology median
Market cap 14.08m 14.27m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack